FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119236166> ?p ?o ?g. }

• W3119236166 abstract "Following the World Health Organization's (WHO) 2015 guidelines recommending initiation of antiretroviral therapy (ART) irrespective of CD4 count for all people living with HIV (PLHIV), many countries in sub-Saharan Africa have adopted this strategy to reach epidemic control. As the number of PLHIV on ART rises, maintenance of viral suppression on ART for over 90% of PLHIV remains a challenge to government health systems in resource-limited high HIV burden settings. Non facility-based antiretroviral therapy (ART) delivery for stable HIV+ patients may increase sustainable ART coverage in resource-limited settings. Within the HPTN 071 (PopART) trial, two models, home-based delivery (HBD) or adherence clubs (AC), were offered to assess whether they achieved similar viral load suppression (VLS) to standard of care (SoC). In this paper, we describe the trial design and discuss the methodological issues and challenges.A three-arm cluster randomized non-inferiority trial, nested in two urban HPTN 071 trial communities in Zambia, randomly allocated 104 zones to SoC (35), HBD (35), or AC (34). ART and adherence support were delivered 3-monthly at home (HBD), adherence clubs (AC), or clinic (SoC). Adult HIV+ patients defined as stable on ART were eligible for inclusion. The primary endpoint was the proportion of PLHIV with virological suppression (≤ 1000 copies HIV RNA/ml) at 12 months (± 3months) after study entry across all three arms. Viral load measurement was done at the routine government laboratories in accordance with national guidelines, annually. The study was powered to determine if either of the community-based interventions would yield a viral suppression rate drop compared to SoC of no more than 5% in its absolute value. Both community-based interventions were delivered by community HIV providers (CHiPs). An additional qualitative study using observations, interviews with PLHIV, and FGDs with community HIV providers was nested in this study to complement the quantitative data.This trial was designed to provide rigorous randomized evidence of safety and efficacy of non-facility-based delivery of ART for stable PLHIV in high-burden resource-limited settings. This trial will inform policy regarding best practices and what is needed to strengthen scale-up of differentiated models of ART delivery in resource-limited settings.ClinicalTrials.gov NCT03025165 . Registered on 19 January 2017." @default.
• W3119236166 created "2021-01-18" @default.
• W3119236166 creator A5002501531 @default.
• W3119236166 creator A5029841050 @default.
• W3119236166 creator A5035626211 @default.
• W3119236166 creator A5043538254 @default.
• W3119236166 creator A5052430873 @default.
• W3119236166 creator A5067056877 @default.
• W3119236166 creator A5067307694 @default.
• W3119236166 creator A5076367823 @default.
• W3119236166 creator A5091777537 @default.
• W3119236166 date "2021-01-12" @default.
• W3119236166 modified "2023-10-14" @default.
• W3119236166 title "A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV+ patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study" @default.
• W3119236166 cites W1531725059 @default.
• W3119236166 cites W1970024313 @default.
• W3119236166 cites W1971246700 @default.
• W3119236166 cites W1980893473 @default.
• W3119236166 cites W1987814835 @default.
• W3119236166 cites W2010696953 @default.
• W3119236166 cites W2032214005 @default.
• W3119236166 cites W2035304784 @default.
• W3119236166 cites W2040201835 @default.
• W3119236166 cites W2057529851 @default.
• W3119236166 cites W2079281604 @default.
• W3119236166 cites W2101116746 @default.
• W3119236166 cites W2108696783 @default.
• W3119236166 cites W2108966822 @default.
• W3119236166 cites W2110884710 @default.
• W3119236166 cites W2113965105 @default.
• W3119236166 cites W2115253919 @default.
• W3119236166 cites W2132241786 @default.
• W3119236166 cites W2133081034 @default.
• W3119236166 cites W2139894829 @default.
• W3119236166 cites W2145438228 @default.
• W3119236166 cites W2146309881 @default.
• W3119236166 cites W2154898661 @default.
• W3119236166 cites W2157890309 @default.
• W3119236166 cites W2164664254 @default.
• W3119236166 cites W2167535574 @default.
• W3119236166 cites W2301154543 @default.
• W3119236166 cites W2734659365 @default.
• W3119236166 cites W2800828057 @default.
• W3119236166 cites W2807247400 @default.
• W3119236166 cites W2883436779 @default.
• W3119236166 cites W2884960397 @default.
• W3119236166 cites W2887834286 @default.
• W3119236166 cites W2905441975 @default.
• W3119236166 doi "https://doi.org/10.1186/s13063-020-05010-w" @default.
• W3119236166 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7802215" @default.
• W3119236166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33430928" @default.
• W3119236166 hasPublicationYear "2021" @default.
• W3119236166 type Work @default.
• W3119236166 sameAs 3119236166 @default.
• W3119236166 citedByCount "4" @default.
• W3119236166 countsByYear W31192361662021 @default.
• W3119236166 countsByYear W31192361662022 @default.
• W3119236166 crossrefType "journal-article" @default.
• W3119236166 hasAuthorship W3119236166A5002501531 @default.
• W3119236166 hasAuthorship W3119236166A5029841050 @default.
• W3119236166 hasAuthorship W3119236166A5035626211 @default.
• W3119236166 hasAuthorship W3119236166A5043538254 @default.
• W3119236166 hasAuthorship W3119236166A5052430873 @default.
• W3119236166 hasAuthorship W3119236166A5067056877 @default.
• W3119236166 hasAuthorship W3119236166A5067307694 @default.
• W3119236166 hasAuthorship W3119236166A5076367823 @default.
• W3119236166 hasAuthorship W3119236166A5091777537 @default.
• W3119236166 hasBestOaLocation W31192361661 @default.
• W3119236166 hasConcept C126322002 @default.
• W3119236166 hasConcept C138885662 @default.
• W3119236166 hasConcept C142462285 @default.
• W3119236166 hasConcept C159110408 @default.
• W3119236166 hasConcept C164866538 @default.
• W3119236166 hasConcept C168563851 @default.
• W3119236166 hasConcept C176400912 @default.
• W3119236166 hasConcept C199360897 @default.
• W3119236166 hasConcept C27415008 @default.
• W3119236166 hasConcept C2778137410 @default.
• W3119236166 hasConcept C2993143319 @default.
• W3119236166 hasConcept C3013748606 @default.
• W3119236166 hasConcept C41008148 @default.
• W3119236166 hasConcept C41895202 @default.
• W3119236166 hasConcept C512399662 @default.
• W3119236166 hasConcept C71924100 @default.
• W3119236166 hasConceptScore W3119236166C126322002 @default.
• W3119236166 hasConceptScore W3119236166C138885662 @default.
• W3119236166 hasConceptScore W3119236166C142462285 @default.
• W3119236166 hasConceptScore W3119236166C159110408 @default.
• W3119236166 hasConceptScore W3119236166C164866538 @default.
• W3119236166 hasConceptScore W3119236166C168563851 @default.
• W3119236166 hasConceptScore W3119236166C176400912 @default.
• W3119236166 hasConceptScore W3119236166C199360897 @default.
• W3119236166 hasConceptScore W3119236166C27415008 @default.
• W3119236166 hasConceptScore W3119236166C2778137410 @default.
• W3119236166 hasConceptScore W3119236166C2993143319 @default.
• W3119236166 hasConceptScore W3119236166C3013748606 @default.
• W3119236166 hasConceptScore W3119236166C41008148 @default.
• W3119236166 hasConceptScore W3119236166C41895202 @default.
• W3119236166 hasConceptScore W3119236166C512399662 @default.
• W3119236166 hasConceptScore W3119236166C71924100 @default.

• next